Trilogy Metals grants 50,000 stock options to director Gowans
Trilogy Metals Inc. (TMQ) reported an insider equity award for director James Gowans.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Trilogy Metals Inc. (TMQ) reported an insider equity award for director James Gowans. On 12/11/2025, he received a director stock option covering 50,000 common shares at an exercise price of $4.61 per share. The option is exercisable starting 12/11/2025 and expires on 12/10/2030.
The exercise price was converted from a Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00, so the award is valued and reported in U.S. dollars for disclosure purposes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (Right to Buy) | 50,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Converted from Canadian exercise price of C$6.35 using an exchange rate of C$1.3774 = US$1.00.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Trilogy Metals Inc. (TMQ) report?
What is the exercise price of the new Trilogy Metals (TMQ) stock options?
How was the Trilogy Metals (TMQ) stock option exercise price converted from Canadian dollars?
When do the newly granted Trilogy Metals (TMQ) options become exercisable and when do they expire?
Who is the reporting person in this Trilogy Metals (TMQ) Form 4 filing?
What type of security was granted to the Trilogy Metals (TMQ) director?
AI-generated analysis. How Rhea-AI works. Not financial advice.